FindTrial
Sign In

GBR 12909 Study in Cocaine Experienced African American Volunteers - 1

GBR 12909 Study in Cocaine Experienced African American Volunteers

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00089687
Enrollment
10
Registered
2004-08-11
Start date
2004-04-30
Completion date
2005-05-31
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine-Related Disorders

Brief summary

The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.

Detailed description

Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.

Interventions

DRUGGBR 12909

Sponsors

National Institute on Drug Abuse (NIDA)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be within 20% of ideal body weight and must weigh at least 45 kg. * Must understand the study procedures and provide written informed consent. * Must meet DSM-4 criteria for abuse or dependence on cocaine. * Must be non-treatment seeking at the time of the study.

Exclusion criteria

* Please contact the study site for more information.

Design outcomes

Primary

MeasureTime frame
pharmacokinetic assessment—

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026